Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cemiplimab Treatment in Patients with Locally Advanced and Metastatic Secondary Angiosarcomas

NCT04873375 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04873375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cemiplimab Treatment in Patients with Locally Advanced and Metastatic Secondary Angiosarcomas
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2022
Completion date
October 18, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced sarcoma, metastasis, secondary angiosarcoma